A redox pathway leading to the alkylation of nucleic acids by doxorubicin and related anthracyclines: Application to the design of antitumor drugs for resistant cancer
Journal Article
Overview
publication date
- June 1, 1998
has subject area
- Aminoglycosides - Anthracyclines
- Aminoglycosides - Doxorubicin
- Antineoplastic Agents
- Biochemical Phenomena - Molecular Structure
- Biological Science Disciplines - Chemistry, Pharmaceutical
- Biological Science Disciplines - Drug Design
- Chemical Phenomena - Molecular Structure
- Chemical Phenomena - Oxidation-Reduction
- Chemistry - Chemistry, Pharmaceutical
- Chemistry - Drug Design
- DNA - DNA Adducts
- DNA Damage - DNA Adducts
- Drug Resistance, Neoplasm
- Energy Metabolism - Oxidation-Reduction
- Hydrocarbons, Aromatic - Anthracyclines
- Hydrocarbons, Aromatic - Doxorubicin
- Investigative Techniques - Drug Design
- Molecular Mechanisms of Pharmacological Action - Alkylating Agents
- Noxae - Alkylating Agents
- Nucleic Acids
- Polycyclic Compounds - Anthracyclines
- Polycyclic Compounds - Doxorubicin
Date in CU Experts
- September 3, 2013 2:59 AM
Full Author List
- Taatjes DJ; Fenick DJ; Gaudiano G; Koch TH
author count
- 4
citation count
- 38
published in
- Current Pharmaceutical Design Journal
Other Profiles
International Standard Serial Number (ISSN)
- 1381-6128
Additional Document Info
start page
- 203
end page
- 218
volume
- 4
issue
- 3